Table of Contents
Bone Marrow Research
Volume 2013, Article ID 565824, 7 pages
http://dx.doi.org/10.1155/2013/565824
Research Article

Validation of the EBMT Risk Score for South Brazilian Patients Submitted to Allogeneic Hematopoietic Stem Cell Transplantation

1Hematology and Bone Marrow Transplantation, Clinical Hospital of Porto Alegre, 90035-903 Porto Alegre, RS, Brazil
2Laboratory of Cell Culture and Molecular Analysis of Hematopoietic Cells, Clinical Hospital of Porto Alegre, 90035-903 Porto Alegre, RS, Brazil

Received 21 August 2013; Revised 4 November 2013; Accepted 6 November 2013

Academic Editor: Peter J. Quesenberry

Copyright © 2013 Beatriz Stela Pitombeira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Copelan, “Hematopoietic stem-cell transplantation,” New England Journal of Medicine, vol. 354, no. 17, pp. 1813–1826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Gyurkocza, A. Rezvani, and R. F. Storb, “Allogeneic hematopoietic cell transplantation: the state of the art,” Expert Review of Hematology, vol. 3, no. 3, pp. 285–299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Lorenz, D. Uphoff, and T. R. Reid, “Modification of irradiation injury in mice and guinea pigs by bone marrow injections,” Journal of the National Cancer Institute, vol. 12, no. 1, pp. 197–201, 1951. View at Google Scholar · View at Scopus
  4. M. Solh, M. Arat, Q. Cao, N. S. Majhail, and D. Weisdorf, “Late-onset noninfectious pulmonary complications in adult allogeneic hematopoietic cell transplant recipients,” Transplantation, vol. 91, no. 7, pp. 798–803, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Hamadani, M. Craig, F. T. Awan, and S. M. Devine, “How we approach patient evaluation for hematopoietic stem cell transplantation,” Bone Marrow Transplantation, vol. 45, no. 8, pp. 1259–1268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. K. Hurley, “HLA diversity: detection and impact on unrelated hematopoietic stem cell donor characterization and selection,” International Journal of Hematology, vol. 76, pp. 152–154, 2002. View at Google Scholar · View at Scopus
  7. B. E. Shaw, P. Veys, A. Pagliuca et al., “Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms,” Bone Marrow Transplantation, vol. 44, no. 1, pp. 7–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. R. A. Bray, C. K. Hurley, N. R. Kamani et al., “National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants,” Biology of Blood and Marrow Transplantation, vol. 14, no. 9, pp. 45–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Aversa, A. Velardi, A. Tabilio, Y. Reisner, and M. F. Martelli, “Haploidentical stem cell transplantation in leukemia,” Blood Reviews, vol. 15, no. 3, pp. 111–119, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Bregni, W. Herr, and D. Blaise, “Allogeneic stem cell transplantation for renal cell carcinoma,” Expert Review of Anticancer Therapy, vol. 11, no. 6, pp. 901–911, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. King, D. L. Confer, H. T. Greinix et al., “Unrelated hematopoietic stem cell donors as research subjects,” Bone Marrow Transplantation, vol. 46, no. 1, pp. 10–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Roziakova and B. Mladosievicova, “Endocrine late effects after hematopoietic stem cell transplantation,” Oncology Research, vol. 18, no. 11-12, pp. 607–615, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Pidala, J. Kim, C. Anasetti et al., “The global severity of chronic graft-versus-host disease, determined by national institutes of health consensus criteria, is associated with overall survival and non-relapse mortality,” Haematologica, vol. 96, no. 11, pp. 1678–1684, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. K. Burnett and S. Knapper, Chapter 3. In: Hematopoietic Stem Cell Transplantation in Clinical Practice, 1e, Churchill Livingstone, London, UK, 2008.
  15. R. Varaldo and F. Frassoni, The EBMT Handbook: Hematopoietic Stem Cell Transplantation, ESH Handbooks, Paris, France, 5th edition, 2008.
  16. H. Döhner, E. H. Estey, S. Amadori et al., “Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet,” Blood, vol. 115, no. 3, pp. 453–474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Gratwohl, M. Stern, R. Brand et al., “Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis,” Cancer, vol. 115, no. 20, pp. 4715–4726, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Gratwohl, J. Hermans, J. M. Goldman et al., “Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation,” The Lancet, vol. 352, no. 9134, pp. 1087–1092, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. C. A. De Souza, A. C. Vigorito, M. A. Ruiz et al., “Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome,” Haematologica, vol. 90, no. 2, pp. 232–237, 2005. View at Google Scholar · View at Scopus
  20. P. G. Hemmati, T. H. Terwey, P. Le Coutre et al., “A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplants,” European Journal of Haematology, vol. 86, no. 4, pp. 305–316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. T. H. Terwey, P. G. Hemmati, P. Martus et al., “A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia,” Haematologica, vol. 95, no. 5, pp. 810–818, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Rezvani, E. J. Kanfer, D. Marin et al., “EBMT risk score predicts outcome of allogeneic hematopoietic stem cell transplantation in patients who have failed a previous transplantation procedure,” Biology of Blood and Marrow Transplantation, vol. 18, no. 2, pp. 235–240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M. C. Pasquini, Z. Wang, M. M. Horowitz, and R. P. Gale, “2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders,” Clinical Transplants, pp. 87–105, 2010. View at Google Scholar · View at Scopus
  24. L. J. N. Cooper, “New approaches to allogeneic hematopoietic stem cell transplantation in pediatric cancers,” Current Oncology Reports, vol. 11, no. 6, pp. 423–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Parimon, D. H. Au, P. J. Martin, and J. W. Chien, “A risk score for mortality after allogeneic hematopoietic cell transplantation,” Annals of Internal Medicine, vol. 144, no. 6, pp. 407–414, 2006. View at Google Scholar · View at Scopus
  26. M. L. Sorror, M. B. Maris, R. Storb et al., “Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT,” Blood, vol. 106, no. 8, pp. 2912–2919, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Xhaard, R. Porcher, J. W. Chien et al., “Impact of comorbidity indexes on non-relapse mortality,” Leukemia, vol. 22, no. 11, pp. 2062–2069, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Gratwohl, “The EBMT risk score,” Bone Marrow Transplantation, vol. 47, no. 6, pp. 749–756, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Allogeneic bone marrow transplantation for leukaemia in Europe, “Report from the working party on leukaemia, European Group for Bone Marrow Transplantation,” The Lancet, vol. 18, pp. 1379–1382, 1988. View at Google Scholar
  30. M. Boeckh and P. Ljungman, “How I treat cytomegalovirus in hematopoietic cell transplant recipients,” Blood, vol. 113, no. 23, pp. 5711–5719, 2009. View at Publisher · View at Google Scholar · View at Scopus